Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.56 USD | +0.80% | -27.59% | +85.29% |
Business Summary
Number of employees: 328
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Harr
FOU | Founder | 53 | 18-07-12 |
Nathan Hardy
DFI | Director of Finance/CFO | 48 | 18-08-31 |
Gary Meininger
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-09 |
Shanna Peek
COO | Chief Operating Officer | - | 19-06-30 |
Edward Rebar
CTO | Chief Tech/Sci/R&D Officer | 56 | 20-02-29 |
Richard Mulligan
CTO | Chief Tech/Sci/R&D Officer | 69 | 18-10-31 |
Ke Liu
LAW | General Counsel | - | 21-01-05 |
Sonja Schrepfer
PRN | Corporate Officer/Principal | 49 | 19-01-31 |
Steven Goldman
PRN | Corporate Officer/Principal | 66 | 20-09-30 |
Terry Fry
PRN | Corporate Officer/Principal | 57 | 20-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 20-04-30 | |
Patrick Yang
BRD | Director/Board Member | 75 | 18-09-30 |
Robert Nelsen
FOU | Founder | 60 | 18-07-12 |
Douglas Cole
BRD | Director/Board Member | 63 | 20-03-31 |
Steven Harr
FOU | Founder | 53 | 18-07-12 |
Josh Bilenker
BRD | Director/Board Member | 52 | 21-01-07 |
Richard Mulligan
CTO | Chief Tech/Sci/R&D Officer | 69 | 18-10-31 |
Hans Bishop
FOU | Founder | 59 | 18-07-12 |
Michelle Seitz
BRD | Director/Board Member | 59 | 20-11-30 |
Alise Reicin
BRD | Director/Board Member | 63 | 20-11-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 221,502,908 | 202,379,939 ( 91.37 %) | 0 | 91.37 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+85.29% | 1.67B | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- SANA Stock
- Company Sana Biotechnology, Inc.